2017
DOI: 10.21276/ap.2017.6.1.3
|View full text |Cite
|
Sign up to set email alerts
|

Reappraisal of actinomycetes for novel bioactive metabolites

Abstract: The appearance of new deadly diseases like cancer and the burgeoning problem of drug resistance among common bacteria l pathogens are a serious threat to a vailable trea tments. Since the channels of compounds under development are limited, this necessitates the discovery of new drugs. It is where actinomycetes can complement in the accomplishment of development of thera peu tically new bioactive compounds, predomina ntly u sed in antibiotic production. Actinomycetes are diverse in their location and have prov… Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2

Citation Types

0
2
0

Year Published

2020
2020
2024
2024

Publication Types

Select...
2
1

Relationship

0
3

Authors

Journals

citations
Cited by 3 publications
(2 citation statements)
references
References 51 publications
0
2
0
Order By: Relevance
“…The infection by PVY results in a wide range of symptoms, such as vein necrosis and systematic mottles, with necrotic ringspots reducing crop yield and quality substantially (Chen et al, 2017). Upon infection, plants activate their defense mechanisms by producing various resistant substances, including phytoalexin chitinase, peroxidase, and plant antitoxin to enhance their tolerance (Shah et al, 2017). Furthermore, the presence of PVY in a host organism leads to the observation of numerous morphological, physiological, and histological alterations (Hinrichs-Berger et al, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…The infection by PVY results in a wide range of symptoms, such as vein necrosis and systematic mottles, with necrotic ringspots reducing crop yield and quality substantially (Chen et al, 2017). Upon infection, plants activate their defense mechanisms by producing various resistant substances, including phytoalexin chitinase, peroxidase, and plant antitoxin to enhance their tolerance (Shah et al, 2017). Furthermore, the presence of PVY in a host organism leads to the observation of numerous morphological, physiological, and histological alterations (Hinrichs-Berger et al, 1999).…”
Section: Introductionmentioning
confidence: 99%
“…Therapies of fungal infections have been restricted by the limited numbers, low safety profiles and emergence of resistance to currently used antifungal agents [ 15 ]. No doubt we are facing a serious public health problem, which highlights the crucial need for the discovery of new specific antifungal agents, preferably from natural resources, particularly those that have not been exploited yet [ 16 ], for instance, soil microbial communities, which have been reported to produce biologically active natural byproducts [ 17 , 18 , 19 , 20 ]. This study is concerned with Lysinibacillus sp., a Gram-positive, rod-shaped bacterium from the family Bacillaceae [ 21 ].…”
Section: Introductionmentioning
confidence: 99%